Skip to main content
B

BIO-GENE TECHNOLOGY LTD — Investor Relations & Filings

Ticker · BGT ISIN · AU000000BGT8 ASX Professional, scientific and technical activities
Filings indexed 449 across all filing types
Latest filing 2024-01-18 Regulatory Filings
Country AU Australia
Listing ASX BGT

About BIO-GENE TECHNOLOGY LTD

https://bio-gene.com.au/

Bio-Gene Technology Ltd is a technology company focused on the development and commercialization of novel insecticides derived from naturally occurring chemistry. The company addresses the global challenge of insecticide resistance through its proprietary platform based on beta-triketone chemistry. Its primary product candidates include Flavocide, a nature-identical version of a compound found in specific eucalyptus species, and Qcide, a natural oil extract. These solutions are designed for diverse applications, including crop protection, grain storage, public health, and animal health. By utilizing a unique mode of action, the company provides alternatives to traditional chemical pesticides, aiming to deliver effective pest management with a favorable safety profile for non-target organisms and the environment.

Recent filings

Filing Released Lang Actions
Bio-Gene Receives R&D Tax Incentive 1 page 635.2KB
Regulatory Filings
2024-01-18 English
BGT Corporate Presentation 21 pages 4.5MB
Regulatory Filings
2023-12-12 English
Investor Webinar - Prof. Catherine Hill and CEO Tim Grogan 36 pages 19.5MB
Regulatory Filings
2023-12-12 English
Investor Webinar - Prof. Catherine Hill and CEO Tim Grogan 2 pages 633.8KB
Regulatory Filings
2023-12-06 English
Bio-Gene to Present at Automic Invest 2023 Conference 1
Regulatory Filings
2023-11-30 English
Becoming a substantial holder 4 pages 951.1KB
Regulatory Filings
2023-11-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.